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SUMMARY 
Background: A gluten-free diet treats coeliac disease, but its efficacy dependents on strict 
adherence. A variety of patient factors may influence adherence but have not been well 
described at a population level.  
Aim: To comprehensively assess the patient factors that influence gluten-free diet adherence 
in patients with coeliac disease. 
Methods: Patients with coeliac disease completed an online survey comprising the validated 
Celiac Dietary Adherence Test in addition to data on demographics, details of diagnosis and 
management and assessment of diet knowledge, quality of life and psychological distress. 
Survey data were analysed for predictors of adherence and quality of life. 
Results: Of 7393 responses, 5310 completed the Celiac Dietary Adherence Test and 3230 
(61%) were adherent to a gluten-free diet. Multivariate regression showed older age, being 
male, symptoms after gluten ingestion, better food knowledge and lower risk of psychological 
distress were independent predictors of adherence (each p≤0.008).  Additionally, dietary 
adherence was associated with better quality of life (p<0.001; multiple regression).  
Respondants who considered themselves to have poor food knowledge were more likely to 
incorrectly identify gluten-free foods, but could still recognise gluten-containing foods, 
suggesting that poor knowledge may lead to over-restriction of diet.    
Conclusions: Poor knowledge of a gluten-free diet and psychological wellbeing were 
independent modifiable risk factors for inadequate adherence to a gluten-free diet in patients 
with coeliac disease.   Involvement of both a dietitian and mental health care professional, in 
the presence of psychological distress, is likely to be necessary to improve adherence and 
health outcomes. 
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INTRODUCTION 
Coeliac disease is a chronic autoimmune condition characterised by small intestinal 
villous atrophy and often presenting with clinical symptoms1.  The only current treatment 
coeliac disease is a strict gluten-free diet to achieve clinical and histological remission, thereby 
reducing risk of associated nutritional deficiencies, infertility, osteoporosis and 
gastrointestinal malignancies2, 3.  The estimated prevalence of coeliac disease is growing, 
particularly in Western countries4, 5, with Australia having one of the highest estimated 
prevalence of approximately 1.5%6.  While a gluten-free diet is considered a safe and largely 
efficacious treatment, it is costly7 and can be socially isolating8, which have been shown to be 
barriers to dietary adherence9-11.  Furthermore, due to the nature of a dietary treatment, 
there is arguably a bigger burden of responsibility on the patient compared to many 
medication-based treatments12.  Patient factors that predict good adherence are therefore 
very relevant to achieving optimal treatment.   
Data on dietary adherence of a gluten-free diet in a coeliac disease population are 
variable, with rates ranging between 42-91%, depending on definition and method of 
assessment13.  Studies from North America and Europe have associated dietary adherence 
with higher levels of education, younger age at diagnosis11, 13, 14, membership of coeliac 
disease advocacy groups10, quality of life and mental disorders15, 16 but sample sizes have been 
small and possibly not representative at a population level. However, examination of clinically 
relevant factors that may be targeted in patient management to improve adherence, such as 
food knowledge, quality of life and psychological distress, have remained unexplored in 
Australia and New Zealand, where there is high prevalence of coeliac disease and stricter 
definition of a gluten-free diet compared to other countries.  The aim of this study was to 
comprehensively assess the patient factors that influence gluten-free diet adherence in 
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patients with coeliac disease in Australia and New Zealand through a large cross-sectional 
survey. A secondary aim was to assess predictors of quality of life, including dietary 
adherence.  It is hypothesised that there will be several factors associated with adherence 
including knowledge and psychological parameters.   
METHODS 
Survey description 
An internet-based survey (SurveyMonkey®; San Mateo, California, USA) was used to 
gather data.  All participants accessed the survey via a web-link.  The survey was advertised 
via Coeliac Australia and Coeliac New Zealand membership communications, state-based 
Gluten Free Expos open to the public, Facebook pages of coeliac disease and word-of-mouth.  
The survey was open for completion for approximately one month.  To capture adults and 
adolescents with established coeliac disease, the advertisement specified that patients 
diagnosed with coeliac disease for at least six months and aged ≥ 13 years were to complete 
the survey.  On entering the survey website, an introductory paragraph described the target 
population and the purpose of the survey, which was to identify predictors of adherence to a 
gluten-free diet.  It specified that only the person with coeliac disease was to complete the 
survey and strict adherence to the diet was not essential for eligibility.  It was confirmed that 
participation was voluntary and any provided personal identifying information was optional 
and kept confidential.   
The survey comprised of 44 questions and took approximately 15 minutes to complete. 
An additional 37 questions were included, to assess psychological factors impacting 
adherence17.  Data from this model are described elsewhere18.  The first question was used 
to obtain consent.  If the participant did not consent to take part in the survey, they were 
directed to the survey completion page.   If consent was obtained, participants were then 
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asked an inclusion criterion question for confirmation of coeliac disease.  Participants were 
directed to the survey completion page if they answered ‘No’ or ‘Unsure’ to the question ‘Do 
you have coeliac disease?’.  
The survey contained the seven-question Celiac Dietary Adherence Test19, a tool 
validated for evaluation of gluten-free diet adherence in a coeliac disease population.  Each 
item is answered using a five-point response scale, where total score of greater than 12 
designates non-adherence to a gluten-free diet (range 7-35).  The rest of the survey was 
designed to capture information related to treatment adherence, including data on 
demographics, coeliac disease diagnosis and management, dietary restrictions (other than 
gluten), questions to assess knowledge of coeliac disease and a gluten-free diet and 
memberships to coeliac disease-related groups.  The Coeliac Disease Quality of Life survey20 
was included, which is a validated measure of quality of life in the studied population.  The 
Coeliac Disease Quality of Life survey uses a five-point response scale for 20 questions (scores 
ranging 20-100) and a higher score indicating a poorer quality of life.  Lastly, the 10-item 
Kessler Psychological Distress Scale was also used to screen for anxiety and mood disorders21, 
22.  Scores for the Kessler Psychological Distress Scale range 10-50 and categorisation of levels 
of psychological distress were based on that previously used in Australian primary healthcare 
settings23; a score less than 20 specifies a person likely to be well, 20-24 likely to have a mild 
mental disorder, 25-29 moderate and scores 30 and over likely to have a severe mental 
disorder.  
 
Survey development 
Besides the validated questions of the Celiac Dietary Adherence Test, Coeliac Disease 
Quality of Life survey and Kessler Psychological Distress Scale, additional questions were 
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developed with input from a panel of clinicians from Australia and UK (gastroenterologists, 
dietitians and psychologists), then tested on lay people with coeliac disease undertaking other 
studies at WEHI and employees of Coeliac Australia and Coeliac New Zealand and their 
feedback considered.  Most volunteers completed the survey within 15 minutes.  Authors 
approved the final version of the survey.   
The questions in the knowledge section were based upon consensus opinion of four 
dietitians with expertise in coeliac disease, which is considered the gold standard for assessing 
knowledge24, 25. The participants were asked i) three dichotomous ‘true or false’ questions 
related to coeliac disease, ii) to distinguish whether eight grains (e.g., corn, buckwheat, spelt) 
were gluten-free or gluten-containing, and iii) to identify whether nine ingredients (e.g., 
soybeans, yeast, barley malt extract) were gluten-free or gluten-containing, all according to 
the FSANZ code26, 27. From this latter knowledge of ingredients, a ‘knowledge score’, 
allocating one point to each correctly answered ingredient out of nine was generated. 
Additionally, participants rated their knowledge on how to adequately follow a gluten-free 
diet according to the categories ‘excellent’, ‘good’, ‘fair’, ‘poor’ and ‘terrible’.   
 
Statistical analyses 
All descriptive data, including participants’ demographics, were non-parametric 
according to D’Agostino’s K-squared test and presented as median and interquartile range. 
Adherence to a gluten-free diet was based upon the validated Celiac Dietary Adherence Test 
score, which defines adequate adherence as a score of 7-12, and inadequate as a score of 13-
3524.  As degree of non-adherence has very little clinical importance, categorical definition of 
adherence was used as the outcome measure.  Multivariate analysis of gender, age, ethnicity, 
level of education, household income, what led to diagnosis (i.e., symptoms, screening or 
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investigation of associated medical condition), symptoms after ingesting gluten, Kessler 
Psychological Distress Scale and knowledge score was performed by logistic regression.  As 
another outcome variable, the same factors were also used in a multiple linear regression 
model to predict the continuous variable of Coeliac Disease Quality of Life survey score.  
Estimated adherence probability were averaged for groupings of age and the Kessler 
Psychological Distress Scale.  Knowledge scores were further analysed by comparison to self-
assessed rating of gluten-free knowledge and likelihood of over- versus under-restriction of 
gluten as defined by incorrect identification of gluten-free and gluten-containing ingredients.   
All statistical analyses were analysed with GraphPad Prism® and regression models were run 
in R® program.  A p-value of ≤ 0.05 was considered statistically significant.   
 
RESULTS 
Survey response 
Of 7393 respondents, 26 did not consent to participating in the survey and a further 183 
(2%) did not have, or were unsure if they had, coeliac disease.  These participants were 
immediately directed to the survey completion page.  Together with 140 subjects who 
dropped out of the survey before completing these two eligibility questions, 7044 participants 
remained for analysis (Figure 1).  The majority of the respondents were alerted to the survey 
via Coeliac Australia or Coeliac New Zealand (4297; 61%), 1921 (27%) through social media 
and the rest via other means.   
 
Demographics 
Demographics of the 7044 respondents are detailed in Supplement 1.  Almost 80% of 
respondents were female, over 36 years of age, and from Australia (80%).   Fourteen percent 
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were from New Zealand, which is a similar response rate to Australia per capita and the vast 
majority were Caucasian (91%).   
 
Diagnosis and management of coeliac disease 
Descriptions of diagnosis and management of the 7044 participants are detailed in 
Table 1.  Most were diagnosed with coeliac disease via gastroscopy and small bowel biopsy 
(84%).  A small proportion of people (2%) claimed to be diagnosed via the non-diagnostic 
methods of HLA genotyping and/or symptoms and the data from those respondents were 
included in the analysis (Table 1).  Approximately half the participants (n = 3591) were 
investigated for coeliac disease due to symptoms; however, almost three-quarters of 
participants (n = 5195) reported symptoms after gluten exposure (Table 1).  Upon diagnosis, 
more than one-third of people had not seen a dietitian for education of a gluten-free diet and, 
of these, many sought information from their state coeliac disease organisation (n = 1567; 
22%), the internet (n = 1281; 18%) and from friends/family (n = 713; 10%); 58 people reported 
having received no information about treatment at all. When asked whether they follow a 
gluten-free diet, 1% (53) of participants responded ‘no’ and the main reasons for non-
adherence were difficulty during travel (n = 22), general difficulty in following the diet (n = 
21), expense (n = 19), lack of symptoms (n = 19) and enjoyment of gluten-containing foods (n 
= 17).  As recommended by the national food standards27, the majority of people do not eat 
oats as part of a gluten-free diet (86%) (Table 1).  A large proportion of people (40%) were 
also restricting another food component, the most common restriction being lactose (n = 
1124), 622 were following a low FODMAP diet, 461 were dairy free, and 303 were pescatarian, 
vegetarian or vegan.   
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Knowledge of coeliac disease and a gluten-free diet 
A total of 6312 participants completed the knowledge questions. Most participants 
rated themselves as excellent (n = 4088; 65%), twice as many as good (n = 2006; 32%), 
followed by fair (n = 194; 3%).  Only 21 and three participants rated themselves as having 
poor and terrible knowledge, respectively.  The knowledge score, based on correct 
identification of nine ingredients as gluten-free or gluten-containing, was associated with self-
assessment of knowledge (perfect score in self-rating categories from ‘excellent’, ‘good’, 
‘fair’, ‘poor’ and ‘terrible’ were 46%, 28%, 17%, 5% and 0, respectively; P < 0.001; chi-square 
analysis). Correct identification of gluten-containing ingredients was similar amongst each 
self-ranked knowledge category; however, participants in a lower self-rating knowledge 
category were less likely to correctly identify gluten-free ingredients (Figure 2), indicating that 
someone with poorer knowledge was more likely to over- than under-restrict their diet.  A 
better self-rated knowledge category was also associated with better understanding of 
coeliac disease (perfect score in descending order of self-rating categories 92%, 90%, 81%, 
71%, 100%; P < 0.001).  Similar results were seen regarding identification of gluten-free and 
gluten-containing grains.  Many people incorrectly identified spelt as gluten-free (19%) and 
buckwheat as gluten-containing (11%).  Membership of Coeliac Australia or Coeliac New 
Zealand was associated with better knowledge (membership 77%, 74%, 61%, 43%, 33%; P < 
0.001).   
 
Quality of life and psychological distress 
Of the 5310 participants who completed the Coeliac Disease Quality of Life survey, 
median[interquartile range(IQR)] Coeliac Disease Quality of Life scores were 44[34-57].  The 
percentage of respondents who fit into the Kessler Psychological Distress Scale for being well, 
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having a mild, moderate and severe mental disorder were 72%, 14%, 7%, 7%, respectively.  
Most people were well (15[12-20]).   
 
Predictors of adherence to a gluten-free diet 
Of the 5310 respondents who completed the Celiac Dietary Adherence Test, 3230 (61%) 
were adherent to a gluten-free diet.  Multivariate association coefficient estimates from a 
logistic regression model with adherence to a gluten-free diet are shown in Table 2. 
Independent predictors of adherence included older age, being male, adverse symptoms 
after gluten ingestion (severe symptoms Odds Ratio (OR) 1.58 compared to no symptoms), 
better knowledge scores in determining gluten-free on food labels (OR 1.19) and lower risk 
of psychological distress indicated by the Kessler Psychological Distress Scale (OR 1.18) (Table 
2).   
The estimated adherence probability increased with age and was poorest between the 
ages of 13 to 26 years and worse with increasing risk of mental disorder according to the 
Kessler Psychological Distress Scale (Figure 3).   
 
Predictors of poorer quality of life 
Independent predictors of a poorer quality of life indicated by the Coeliac Disease 
Quality of Life score are shown in Table 3.  Age, severity of symptoms after gluten ingestion, 
psychological distress and adherence to a gluten-free diet were found to be significant 
predictors of quality of life (Table 3). Specifically, poorer quality of life was significantly 
associated with a younger age, possibly due to the impact of coeliac disease on the social 
lifestyle in younger people.  Unsurprisingly, the more severe the symptoms, the greater the 
impact on quality of life (Table 3).  The impact of severe symptoms on quality of life was 
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estimated to be nearly three times as large as that seen in those with moderate symptoms 
(coefficient estimate of 3.05 for severe symptom versus 1.17 for moderate symptoms; Table 
3). Additionally, greater likelihood of psychological distress, as indicated by the Kessler 
psychological distress scale, was also found to be associated with lower quality of life (Table 
3).  Lastly, non-adherence to a gluten-free diet was estimated to have almost the same level 
of negative impact on quality of life as the presence of severe symptoms after gluten ingestion 
(Table 3).   
 
DISCUSSION 
Adherence to a gluten-free diet is crucial for adequate treatment of coeliac disease, but 
adherence rates vary greatly.  Difficulties in determining rates and predictors of adherence 
may be due to small sample sizes of past studies.  This survey-based study of over 7000 people 
with coeliac disease is the largest of its kind, both within Australasia, and worldwide.  Of the 
5310 survey respondents who provided adherence data, 61% had excellent or very good 
adherence to a gluten-free diet.  It is important to acknowledge that there were a large 
proportion of respondents who were members of their coeliac disease advocacy 
organisations (68%). It is probable these respondents are more informed and health 
conscious, so the rate of adherence described may over-estimate what is seen in the general 
coeliac disease population, although 61% is comparable to other studies utilising the Celiac 
Dietary Adherence Test28, 29.  
Independent predictors of adherence were male gender, older age, more severe 
symptoms associated with gluten ingestion, better knowledge scores and lower psychological 
levels of distress. Factors such as adverse symptoms and food knowledge associating with 
better adherence are both predictable and consistent with previous research25, 30. An 
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interesting finding in this study was that people with self-perceived poorer knowledge in 
reading labels were more likely to incorrectly identify gluten-free foods but could still 
recognise gluten-containing foods, yet, were more likely to be non-adherent.  A barrier to 
good adherence in some patients could be the perception that a gluten-free diet is more 
restrictive and harder than it actually is.  These data suggest that referring non-adherent 
patients to a dietitian may be of value if their knowledge level in applying a gluten-free diet 
is poor. On the other hand, psychological distress was very common amongst people with 
coeliac disease who were non-adherent. In the presence of an underlying mental health 
problem, mental health assessment is appropriate and treatment may potentially support 
improved adherence, particularly if assessment of their knowledge skills19, 25 is deemed 
adequate.  The proportion of people with elevated psychopathology, indicated by Kessler 
Psychological Distress Scale, is comparable to other studies conducted in patients with coeliac 
disease31.  While being male and older are unexpected factors associated with adherence to 
a gluten-free diet, these factors are non-modifiable and potentially, the older age may 
indicate a longer time since diagnosis.  Screening studies indicate coeliac disease affects a 
higher proportion of females in Australia and New Zealand32, 33 and this sex bias is particularly 
prominent in diagnosed members of the national patient groups, Coeliac Australia and Coeliac 
New Zealand (4F:1M; personal communication, Coeliac Australia and Coeliac NZ). Thus, this 
study sample appears quite representative of the sex distribution of people actually 
diagnosed with coeliac disease however an undetected sex bias could potentially affect 
results. 
Quality of life was assessed as a separate outcome variable because literature has been 
conflicting in whether people with treated coeliac disease had better or worse quality of life 
than the general population34, 35.  These past studies were conducted in different times and 
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countries, so perhaps the quality of life was more reflective of ease of application of 
treatment.  Anecdotally, a gluten-free diet is becoming easier to apply in Australia in recent 
years, as indicated by increased variety and choice of gluten-free manufactured food products 
and improving availability in restaurants in metropolitan Australian cities36.  The current 
findings indicate that good adherence to a gluten-free diet was associated with the presence 
of increasing symptom severity after gluten ingestion.  It may be that application of a gluten-
free diet is less onerous than in past times and the improved health outcomes, including 
symptoms, now outweigh the difficulties of the diet in a proportion of patients.   
While not the main aim of this study, an added benefit of completing a survey of this 
considerable magnitude is that it allows acquisition of important data on diagnosis and 
management of Australians and New Zealanders with coeliac disease.  These findings suggest 
that the method of diagnosis of coeliac disease is much better than expected37, 38, with 84% 
being adequately diagnosed via gastroscopy and small bowel biopsy, the current gold 
standard of diagnosis1.  Only 2% of survey respondents were inappropriately diagnosed by 
non-diagnostic methods and the data from those respondents were included in analysis.  
Again, this may be impacted by the high rates of respondents who are members of their state 
coeliac disease organisation.  It is expected that more motivated people complete surveys, 
but even recent Australian survey data have showed that the majority of people who follow 
a gluten-free diet do not have adequate investigation of coeliac disease37, although this was 
a different population studied.  Perhaps more surprising information is that over one-third of 
people diagnosed with coeliac disease have never seen a dietitian and will rely on the 
internet, friends/family for their information of treatment.  This may be an explanation for 
the general poor rates of food knowledge amongst the survey respondents and specifically 
the poor ability to identify gluten-free food (Figure 2).  Indeed, the most common complaint 
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of survey respondents who did not follow a gluten-free diet was experiencing difficulty in 
following the diet in all or some environments, such as while travelling.  These findings 
support consensus treatment guidelines that stress the importance of newly diagnosed 
patients having thorough education of a gluten-free diet, including advice on diet 
practicalities, preferably from a dietitian with expertise in coeliac disease39, 40.  Additionally, 
as a large proportion of people are also restricting other food components, such as lactose 
and FODMAPs (16% and 9%, respectively), expert advice on how to minimise excessive 
restriction and ensure nutritional adequacy that is tailored to each individual patient’s needs 
is indicated.   
Cross-sectional survey evaluation of adherence to a gluten-free diet in Australian and 
New Zealander patients with coeliac disease showed that poor knowledge of applying a 
gluten-free diet and reduced psychological wellbeing were independent modifiable risk 
factors for inadequate adherence to a gluten-free diet.   Dietitian involvement in patient 
management and involvement of a mental health care professional in the presence of 
psychological distress should improve adherence and health outcomes.   
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Table 1. Diagnosis and management of coeliac disease in 7044 people with coeliac disease 
who consented and participated in a survey distributed amongst Australians and New 
Zealanders 
Characteristic Options n (%) 
How coeliac disease was diagnosed Coeliac serology only 472 (7) 
Small bowel biopsy only 2609 (37) 
Both serology & small bowel biopsy 3312 (47) 
Neither – based only on symptoms 
and/or genetic testing 
176 (2) 
No response 475 (7) 
What led to coeliac disease diagnosis Symptoms 3591 (51) 
Associated medical condition 1658 (24) 
Family history screening 473 (7) 
Incidental 847 (12) 
No response 475 (7) 
Regular review with medical 
professional 
No 2599 (37) 
Yes 3970 (56) 
No response 475 (7) 
Source of gluten-free diet information General dietitian 2297 (33) 
Dietitian specialising in coeliac 
disease 
1690 (24) 
No dietitian 2582 (37) 
No response 475 (7) 
Membership to Coeliac 
Australia/Coeliac New Zealand 
Yes 4782 (68) 
No, lapsed member 699 (10) 
No, never been member 817 (12) 
No response 746 (11) 
Symptoms after gluten ingestion No 851 (12) 
Yes, mild 1007 (14) 
Yes, moderate 1823 (26) 
Yes, severe 2365 (34) 
Unsure 523 (7) 
No response 475 (7) 
Co-morbidities Osteoporosis/osteopenia 1676 (24) 
Iron deficiency 1420 (20) 
Other autoimmune disease 1370 (19) 
Following a gluten-free diet Yes 6481 (92) 
No 53 (1) 
No response 510 (7) 
Ingestion of oats No 6058 (86) 
Yes 127 (2) 
Yes, only wheat-free 349 (5) 
No response 510 (7) 
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Table 2. Logistic regression model showing independent predictors of adherence to a gluten-
free diet in 5310 Australians and New Zealanders with coeliac disease 
Variable Gluten-
free diet 
adherence 
(%) 
Coefficient 
estimate 
Estimated OR P value 
Female 61 -0.209 0.811 0.018 
Age* 61 0.009 1.01 < 0.001 
Caucasian 61 0.497 1.64 0.121 
Level of education completed: 
Secondary school 
TAFE course/equivalent 
Bachelor degree 
Masters degree or higher 
 
62 
 
0.028 
 
1.03 
 
0.819 
59 0.043 1.04 0.711 
62 0.084 1.09 0.451 
66 0.138 1.15 0.204 
Household annual income: 
$50 000 - $100 000 
$100 000 - $200 000 
> $200 000 
 
60 
 
-0.025 
 
0.976 
 
0.778 
61 0.018 1.02 0.842 
68 0.132 1.14 0.307 
Reason for investigations†: 
Associated medical condition 
Family history screening 
Incidental 
 
64 
 
0.092 
 
1.10 
 
0.241 
59 -0.023 0.977 0.853 
60 -0.066 0.937 0.521 
Symptoms after gluten exposure±: 
No 
Moderate 
Severe 
Unsure 
 
60 
 
-0.150 
 
0.861 
 
0.208 
61 0.369 1.45 < 0.001 
61 0.458 1.58 < 0.001 
65 0.379 1.46 0.008 
Knowledge score* 61 0.171 1.19 < 0.001 
Kessler Psychological Distress Scale* 61 -0.167 0.846 < 0.001 
OR Odds ratio 
Adherence is based on a Celiac Dietary Adherence Test score of < 13  
Statistically significant predictors are shown in bold.  Higher Kessler Psychological Distress 
Scale indicates greater likelihood of psychological distress  
* Continuous variable 
† Compared to symptoms 
± Compared to mild symptoms 
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Table 3. Multivariate analysis, using a multiple linear regression model showing independent 
predictors of quality of life according to the validated Coeliac Disease Quality of Life score in 
5310 Australians and New Zealanders with coeliac disease.  Higher Coeliac Disease Quality of 
Life score indicate poorer quality of life. 
Variable Coefficient estimate P value 
Female -0.137 0.773 
Age* -0.138 < 0.001 
Caucasian -0.518 0.780 
Level of education completed: 
Secondary school 
TAFE course/equivalent 
Bachelor degree 
Masters degree or higher 
 
0.156 
 
0.813 
0.904 0.151 
-0.167 0.784 
-0.765 0.196 
Household annual income: 
$50 000 - $100 000 
$100 000 - $200 000 
> $200 000 
 
0.477 
 
0.320 
0.060 0.906 
0.084 0.904 
Reason for investigations†: 
Associated medical condition 
Family history screening 
Incidental 
 
0.346 
 
0.419 
-0.229 0.743 
0.975 0.082 
Symptoms after gluten exposure±: 
No 
Moderate 
Severe 
Unsure 
 
0.399 
 
0.551 
1.17 0.035 
3.05 < 0.001 
2.09 0.007 
Knowledge score* -0.098 0.437 
Kessler Psychological Distress Scale* 1.14 < 0.001 
Adherence -3.25 < 0.001 
Statistically significant predictors are shown in bold 
Higher Kessler Psychological Distress Scale indicates greater likelihood of psychological 
distress 
Adherence is based on a Celiac Dietary Adherence Test score of < 13  
* Continuous variable 
† Compared to symptoms 
± Compared to mild symptoms 
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Figure legend 
Figure 1.  Flow diagram describing participation in a survey aimed at Australians and New 
Zealanders with coeliac disease 
 
Figure 2.  Self-assessment of ability to adequately apply a gluten-free diet compared to 
percentage of correctly identifying gluten containing and gluten-free ingredients in 6312 
people with coeliac disease.  There are significant differences among correct identification of 
ingredients in the groups of patients who rated themselves as ‘excellent’, ‘good’ and ‘fair’ 
knowledge (chi-squared analysis).   
 
Figure 3. Estimated adherence probability in people with coeliac disease across a) different 
age groups, and b) varying Kessler Psychological Distress Scale.  Adherence was different 
amongst categories (chi-squared analysis).  Categories for Kessler Psychological Distress Scale 
scores < 20 indicates likely to be well, 20-24 indicates likely to have a mild mental disorder, 
25-90 indicates likely to have a moderate mental disorder and ≥ 30 likely to have a severe 
mental disorder. 
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STROBE Statement—Checklist of items that should be included in reports of cross-sectional studies  
 
Item 
No Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or 
the abstract 
(b) Provide in the abstract an informative and balanced summary of what 
was done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation 
being reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection 
of participants 
Variables 7 Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods 
of assessment (measurement). Describe comparability of assessment 
methods if there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If 
applicable, describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) If applicable, describe analytical methods taking account of sampling 
strategy 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers 
potentially eligible, examined for eligibility, confirmed eligible, included 
in the study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, 
social) and information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of 
interest 
Outcome data 15* Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted 
estimates and their precision (eg, 95% confidence interval). Make clear 
which confounders were adjusted for and why they were included 
(b) Report category boundaries when continuous variables were 
categorized 
(c) If relevant, consider translating estimates of relative risk into absolute 
risk for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, 
and sensitivity analyses 
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Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential 
bias or imprecision. Discuss both direction and magnitude of any 
potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and 
other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present 
study and, if applicable, for the original study on which the present 
article is based 
 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological 
background and published examples of transparent reporting. The STROBE checklist is best used in conjunction 
with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals 
of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on 
the STROBE Initiative is available at www.strobe-statement.org. 
 
